Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

The influence of Streptococcus pneumoniae nasopharyngeal colonization on the clinical outcome of the respiratory tract infections in preschool children

Authors: Sigita Petraitiene, Tomas Alasevicius, Indre Staceviciene, Daiva Vaiciuniene, Tomas Kacergius, Vytautas Usonis

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Streptococcus pneumoniae (SPn) is an important pathogen causing a variety of clinical manifestations. The effects of SPn nasopharyngeal colonization on respiratory tract infections are poorly studied. We evaluated the association of SPn colonization with features of respiratory tract infections.

Methods

Children under the age of 6 years who visited a primary care physician because of respiratory tract infections were enrolled in the study. History was taken, children were clinically assessed by the physician, and nasopharyngeal swabs were obtained and cultured for SPn. Positive samples were serotyped. Associations of SPn colonization with clinical signs and symptoms, recovery duration, absence from day care centre, frequencies of specific diagnoses, and treatment with antimicrobials were evaluated.

Results

In total 900 children were enrolled. The prevalence of SPn colonization was 40.8 % (n = 367). There were minor differences between male and female subjects (199 of 492, 40.4 % vs 168 of 408, 41.2 %, p = 0.825). Children with and without siblings had similar colonization rates (145 of 334, 43.4 % vs 219 of 562, 39.0 %, p = 0.187). Clinical signs and symptoms were not associated with SPn colonization. Children colonized with SPn had longer recovery duration compared to non-colonized children (114 of 367, 31.1 % vs 98 of 533, 18.4 %, p < 0.001) and were longer absent from day care (270 of 608, 44.4 % vs 94 of 284, 33.1 %, p = 0.001). Pneumonia, sinusitis, and acute otitis media were more frequently diagnosed in children colonized with SPn. Children attending day care centres had significantly higher prevalence of SPn colonization (270 of 367, 44.4 % vs 338 of 533, 33.1 %, p = 0.001). Children with pneumonia, sinusitis and acute otitis media were more frequently treated with antimicrobials than children with other diagnoses.

Conclusions

SPn nasopharyngeal colonization has a negative impact on the course of respiratory tract infection, likely because of SPn being the cause of the disease or a complicating factor. It is also associated with and may be responsible for higher frequencies of bronchitis, pneumonia, acute otitis media, sinusitis and the need of antimicrobial treatment.
Literature
1.
go back to reference O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902.CrossRefPubMed O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902.CrossRefPubMed
2.
go back to reference Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol. 2013;21:129–35.CrossRefPubMed Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol. 2013;21:129–35.CrossRefPubMed
3.
5.
go back to reference Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis. 2009;199:776–85.CrossRefPubMed Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis. 2009;199:776–85.CrossRefPubMed
6.
go back to reference Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine–United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59:253–7. Centers for Disease Control and Prevention (CDC). Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine–United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59:253–7.
7.
go back to reference von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A, et al. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine. 2013;31:4200–8.CrossRef von Gottberg A, Cohen C, de Gouveia L, Meiring S, Quan V, Whitelaw A, et al. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine. 2013;31:4200–8.CrossRef
8.
go back to reference Tardivo S, Poli A, Zerman T, D’Elia R, Chiamenti G, Torri E, et al. Invasive pneumococcal infections in infants up to three years of age: results of a longitudinal surveillance in North-East Italy. Ann Ig. 2009;21:619–28.PubMed Tardivo S, Poli A, Zerman T, D’Elia R, Chiamenti G, Torri E, et al. Invasive pneumococcal infections in infants up to three years of age: results of a longitudinal surveillance in North-East Italy. Ann Ig. 2009;21:619–28.PubMed
9.
go back to reference Soley C, Arguedas A. Understanding the link between pneumococcal serotypes and invasive disease. Vaccine. 2009;27:C19–21.CrossRefPubMed Soley C, Arguedas A. Understanding the link between pneumococcal serotypes and invasive disease. Vaccine. 2009;27:C19–21.CrossRefPubMed
10.
go back to reference Guevara M, Barricarte A, Gil-Setas A, Garcia-Irure JJ, Beristain X, Torroba L, et al. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect. 2009;15:1013–9.CrossRefPubMed Guevara M, Barricarte A, Gil-Setas A, Garcia-Irure JJ, Beristain X, Torroba L, et al. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect. 2009;15:1013–9.CrossRefPubMed
11.
go back to reference Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J. 2014;33 Suppl 2:S140–51.CrossRefPubMed Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J. 2014;33 Suppl 2:S140–51.CrossRefPubMed
12.
go back to reference Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J. 2014;33 Suppl 2:S109–18.CrossRefPubMed Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J. 2014;33 Suppl 2:S109–18.CrossRefPubMed
13.
go back to reference De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine. 2009;27:2877–83.CrossRefPubMed De Wals P, Erickson L, Poirier B, Pépin J, Pichichero ME. How to compare the efficacy of conjugate vaccines to prevent acute otitis media? Vaccine. 2009;27:2877–83.CrossRefPubMed
14.
go back to reference Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32:805–9.PubMedPubMedCentral Casey JR, Kaur R, Friedel VC, Pichichero ME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, New York. Pediatr Infect Dis J. 2013;32:805–9.PubMedPubMedCentral
15.
go back to reference Pelton SI. Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr Clin North Am. 2005;52:711–28. v-vi.CrossRefPubMed Pelton SI. Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr Clin North Am. 2005;52:711–28. v-vi.CrossRefPubMed
16.
go back to reference Caeymaex L, Varon E, Levy C, Bechet S, Derkx V, Desvignes V, et al. Characteristics and outcomes of acute otitis media in children carrying Streptococcus pneumoniae or Haemophilus influenzae in their nasopharynx as a single otopathogen after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;33:533–6.CrossRef Caeymaex L, Varon E, Levy C, Bechet S, Derkx V, Desvignes V, et al. Characteristics and outcomes of acute otitis media in children carrying Streptococcus pneumoniae or Haemophilus influenzae in their nasopharynx as a single otopathogen after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;33:533–6.CrossRef
17.
go back to reference Zhao AS, Boyle S, Butrymowicz A, Engle RD, Roberts JM, Mouzakes J. Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology. Int J Pediatr Otorhinolaryngol. 2014;78:499–503.CrossRefPubMed Zhao AS, Boyle S, Butrymowicz A, Engle RD, Roberts JM, Mouzakes J. Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology. Int J Pediatr Otorhinolaryngol. 2014;78:499–503.CrossRefPubMed
18.
go back to reference National Hospital Ambulatory Medical Care Survey. 2010 Emergency department summary tables. Centers for Disease Control and Prevention. 2010. National Hospital Ambulatory Medical Care Survey. 2010 Emergency department summary tables. Centers for Disease Control and Prevention. 2010.
20.
go back to reference Usonis V, Stacevičienė I, Petraitienė S, Vaičiūnienė D, Alasevičius T, Kirslienė J. Streptococcus pneumoniae nasopharyngeal colonisation in children aged under six years with acute respiratory tract infection in Lithuania, February 2012 to March 2013. Euro Surveill. 2015;20:13.CrossRef Usonis V, Stacevičienė I, Petraitienė S, Vaičiūnienė D, Alasevičius T, Kirslienė J. Streptococcus pneumoniae nasopharyngeal colonisation in children aged under six years with acute respiratory tract infection in Lithuania, February 2012 to March 2013. Euro Surveill. 2015;20:13.CrossRef
21.
go back to reference Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38:632–9.CrossRefPubMed Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis. 2004;38:632–9.CrossRefPubMed
22.
go back to reference Hoti F, Erasto P, Leino T, Auranen K. Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland–implications for elimination of transmission. BMC Infect Dis. 2009;9:102.CrossRefPubMedPubMedCentral Hoti F, Erasto P, Leino T, Auranen K. Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland–implications for elimination of transmission. BMC Infect Dis. 2009;9:102.CrossRefPubMedPubMedCentral
23.
go back to reference Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.CrossRefPubMed Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.CrossRefPubMed
24.
go back to reference O’Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis. 2007;196:1211–20.CrossRefPubMed O’Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis. 2007;196:1211–20.CrossRefPubMed
25.
go back to reference Hare KM, Stubbs E, Beissbarth J, Morris PS, Leach AJ. Swab transport in Amies gel followed by frozen storage in skim milk tryptone glucose glycerol broth (STGGB) for studies of respiratory bacterial pathogens. J Microbiol Methods. 2010;81:253–5.CrossRefPubMed Hare KM, Stubbs E, Beissbarth J, Morris PS, Leach AJ. Swab transport in Amies gel followed by frozen storage in skim milk tryptone glucose glycerol broth (STGGB) for studies of respiratory bacterial pathogens. J Microbiol Methods. 2010;81:253–5.CrossRefPubMed
27.
go back to reference Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32:165–79.CrossRefPubMed Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32:165–79.CrossRefPubMed
28.
go back to reference Nunes S, Sa-Leao R, de Lencastre H. Optochin resistance among Streptococcus pneumoniae strains colonizing healthy children in Portugal. J Clin Microbiol. 2008;46:321–4.CrossRefPubMed Nunes S, Sa-Leao R, de Lencastre H. Optochin resistance among Streptococcus pneumoniae strains colonizing healthy children in Portugal. J Clin Microbiol. 2008;46:321–4.CrossRefPubMed
29.
go back to reference Otsuka T, Chang B, Shirai T, Iwaya A, Wada A, Yamanaka N, et al. Individual risk factors associated with nasopharyngeal colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study. Pediatr Infect Dis J. 2013;32:709–14.CrossRefPubMed Otsuka T, Chang B, Shirai T, Iwaya A, Wada A, Yamanaka N, et al. Individual risk factors associated with nasopharyngeal colonization with Streptococcus pneumoniae and Haemophilus influenzae: a Japanese birth cohort study. Pediatr Infect Dis J. 2013;32:709–14.CrossRefPubMed
30.
go back to reference Kristo A, Uhari M, Kontiokari T, Glumoff V, Kaijalainen T, Leinonen M, et al. Nasal middle meatal specimen bacteriology as a predictor of the course of acute respiratory infection in children. Pediatr Infect Dis J. 2006;25:108–12.CrossRefPubMed Kristo A, Uhari M, Kontiokari T, Glumoff V, Kaijalainen T, Leinonen M, et al. Nasal middle meatal specimen bacteriology as a predictor of the course of acute respiratory infection in children. Pediatr Infect Dis J. 2006;25:108–12.CrossRefPubMed
31.
go back to reference Vu HT, Yoshida LM, Suzuki M, Nguyen HA, Nguyen CD, Nguyen AT, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;30:11–8.CrossRefPubMed Vu HT, Yoshida LM, Suzuki M, Nguyen HA, Nguyen CD, Nguyen AT, et al. Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J. 2011;30:11–8.CrossRefPubMed
32.
go back to reference van Bijnen EM, den Heijer CD, Paget WJ, Stobberingh EE, Verheij RA, Bruggeman CA, et al. The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infect Dis. 2011;11:293.CrossRefPubMedPubMedCentral van Bijnen EM, den Heijer CD, Paget WJ, Stobberingh EE, Verheij RA, Bruggeman CA, et al. The appropriateness of prescribing antibiotics in the community in Europe: study design. BMC Infect Dis. 2011;11:293.CrossRefPubMedPubMedCentral
33.
go back to reference Chiappini E, Venturini E, Galli L, Novelli V, de Martino M. Diagnostic features of community-acquired pneumonia in children: what’s new? Acta Paediatr Suppl. 2013;102:17–24.CrossRef Chiappini E, Venturini E, Galli L, Novelli V, de Martino M. Diagnostic features of community-acquired pneumonia in children: what’s new? Acta Paediatr Suppl. 2013;102:17–24.CrossRef
34.
go back to reference Shaikh N, Hoberman A, Kearney DH, Colborn DK, Kurs-Lasky M, Jeong JH, et al. Signs and symptoms that differentiate acute sinusitis from viral upper respiratory tract infection. Pediatr Infect Dis J. 2013;32:1061–5.CrossRefPubMedPubMedCentral Shaikh N, Hoberman A, Kearney DH, Colborn DK, Kurs-Lasky M, Jeong JH, et al. Signs and symptoms that differentiate acute sinusitis from viral upper respiratory tract infection. Pediatr Infect Dis J. 2013;32:1061–5.CrossRefPubMedPubMedCentral
35.
go back to reference Ozdemir H, Ciftci E, Durmaz R, Guriz H, Aysev AD, Karbuz A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Eur J Pediatr. 2013;173:313–20.CrossRefPubMed Ozdemir H, Ciftci E, Durmaz R, Guriz H, Aysev AD, Karbuz A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule. Eur J Pediatr. 2013;173:313–20.CrossRefPubMed
36.
go back to reference Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, et al. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J. 2013;32:e45–53.CrossRefPubMed Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, et al. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J. 2013;32:e45–53.CrossRefPubMed
37.
go back to reference Lee EK, Jun JK, Choi UY, Kwon HJ, Kim KH, Kang JH. Nasopharyngeal carriage rate and serotypes of and antimicrobial susceptibility in healthy Korean children younger than 5 years Old: focus on influence of pneumococcal conjugate vaccination. Infect Chemother. 2013;45:76–84.CrossRefPubMedPubMedCentral Lee EK, Jun JK, Choi UY, Kwon HJ, Kim KH, Kang JH. Nasopharyngeal carriage rate and serotypes of and antimicrobial susceptibility in healthy Korean children younger than 5 years Old: focus on influence of pneumococcal conjugate vaccination. Infect Chemother. 2013;45:76–84.CrossRefPubMedPubMedCentral
38.
go back to reference Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage. Pediatr Infect Dis J. 2014;33 Suppl 2:S152–60.CrossRefPubMed Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage. Pediatr Infect Dis J. 2014;33 Suppl 2:S152–60.CrossRefPubMed
39.
go back to reference Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403–9.CrossRefPubMed Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403–9.CrossRefPubMed
40.
go back to reference Shapiro DJ, Gonzales R, Cabana MD, Hersh AL. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics. 2011;127:28–34.CrossRefPubMed Shapiro DJ, Gonzales R, Cabana MD, Hersh AL. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics. 2011;127:28–34.CrossRefPubMed
Metadata
Title
The influence of Streptococcus pneumoniae nasopharyngeal colonization on the clinical outcome of the respiratory tract infections in preschool children
Authors
Sigita Petraitiene
Tomas Alasevicius
Indre Staceviciene
Daiva Vaiciuniene
Tomas Kacergius
Vytautas Usonis
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-1149-8

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine